Astria Therapeutics, Inc.
Astria Therapeutics, Inc. (ATXS) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 16 transactions totaling $51.8M, demonstrating a bullish sentiment with $51.3M in net insider flow. The most recent transaction on Apr 1, 2024 involved a sale of 10,000 shares valued at $135.9K.
ATXS Insider Activity Summary
Who Is Buying ATXS Stock?
No significant insider buying has been recorded for ATXS in the recent period.
Who Is Selling ATXS Stock?
No significant insider selling has been recorded for ATXS in the recent period.
Is Astria Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ATXS is bullish with an Insider Alignment Score of 100/100 and a net flow of $51.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ATXS Frequently Asked Questions
Understanding ATXS Insider Activity
Insider trading at Astria Therapeutics, Inc. (ATXS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading ATXS stock, having executed 16 transactions in the past 90 days. The most active insider is Xontogeny Venture Fund, Lp Perceptive (Executive), who has made 1 transactions totaling $30.0M.
Related Tools
Track Astria Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ATXS file new Form 4 transactions